ARMP insider filings

Armata Pharmaceuticals, Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-07-14. Screen ARMP transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for ARMP between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — Armata Pharmaceuticals, Inc.

FiledFormInsiderReported transactionsSource
2026-07-144Birx Deborah — Chief Executive Officer, DirectorTax withholding (F): 14,041 @ $4.26EDGAR
2026-04-284Gilmer Daniel B. — DirectorGrant/award (A): 51,280 (derivative) @ $0EDGAR
2026-03-174Kyme Pierre — Chief Business OfficerTax withholding (F): 1,030 @ $10.54EDGAR
2026-03-174Birx Deborah — Chief Executive Officer, DirectorTax withholding (F): 4,919 @ $10.54EDGAR
2026-03-114House David Duane — SVP, Finance, and PFOGrant/award (A): 109,885 (derivative) @ $0EDGAR
2026-03-114Kyme Pierre — Chief Business OfficerGrant/award (A): 183,142 (derivative) @ $0EDGAR
2026-03-114Birx Deborah — Chief Executive Officer, DirectorGrant/award (A): 421,226 (derivative) @ $0EDGAR
2026-03-114Peterson Todd C. — DirectorGrant/award (A): 25,640 (derivative) @ $0EDGAR
2026-03-114Kramer Robin — DirectorGrant/award (A): 25,640 (derivative) @ $0EDGAR
2026-03-114Schlesinger Sarah J. — DirectorGrant/award (A): 25,640 (derivative) @ $0EDGAR
2026-03-114Odysseas Kostas D — DirectorGrant/award (A): 25,640 (derivative) @ $0EDGAR
2026-03-114Haimovitz Jules — DirectorGrant/award (A): 25,640 (derivative) @ $0EDGAR
2026-03-114PATTI JOSEPH M — DirectorGrant/award (A): 25,640 (derivative) @ $0EDGAR
2025-07-144Birx Deborah — Chief Executive Officer, DirectorTax withholding (F): 13,637 @ $2.27EDGAR
2025-04-254Kyme Pierre — Chief Business OfficerTax withholding (F): 1,027 @ $1.95EDGAR
2025-04-254Birx Deborah — Chief Executive Officer, DirectorTax withholding (F): 22,925 @ $2.68 · Tax withholding (F): 6,061 @ $1.95EDGAR
2025-02-074House David Duane — SVP, Finance, and PFOGrant/award (A): 25,000 (derivative) @ $0EDGAR
2025-02-074Kyme Pierre — Chief Business OfficerGrant/award (A): 100,000 (derivative) @ $0EDGAR
2025-02-074Birx Deborah — Chief Executive Officer, DirectorGrant/award (A): 240,000 (derivative) @ $0EDGAR
2025-02-074Peterson Todd C. — DirectorGrant/award (A): 54,343 (derivative) @ $0EDGAR
2025-02-074Kramer Robin — DirectorGrant/award (A): 54,343 (derivative) @ $0EDGAR
2025-02-074Schlesinger Sarah J. — DirectorGrant/award (A): 54,343 (derivative) @ $0EDGAR
2025-02-074Odysseas Kostas D — DirectorGrant/award (A): 54,343 (derivative) @ $0EDGAR
2025-02-074Haimovitz Jules — DirectorGrant/award (A): 54,343 (derivative) @ $0EDGAR
2025-02-074PATTI JOSEPH M — DirectorGrant/award (A): 54,343 (derivative) @ $0EDGAR
2024-10-034House David Duane — SVP, Finance, and PFOGrant/award (A): 75,000 (derivative) @ $0EDGAR
2024-03-184Rychlik Richard — Corporate Controller and PFOGrant/award (A): 10,000 @ $0 · Grant/award (A): 40,000 (derivative) @ $0EDGAR
2024-03-184Birx Deborah — Chief Executive Officer, DirectorGrant/award (A): 60,000 @ $0 · Grant/award (A): 240,000 (derivative) @ $0EDGAR
2024-03-184Peterson Todd C. — DirectorGrant/award (A): 39,666 (derivative) @ $0 · Grant/award (A): 54,343 (derivative) @ $0EDGAR
2024-03-184Kramer Robin — DirectorGrant/award (A): 39,666 (derivative) @ $0 · Grant/award (A): 54,343 (derivative) @ $0EDGAR
2024-03-184Schlesinger Sarah J. — DirectorGrant/award (A): 39,666 (derivative) @ $0 · Grant/award (A): 54,343 (derivative) @ $0EDGAR
2024-03-184Odysseas Kostas D — DirectorGrant/award (A): 39,666 (derivative) @ $0 · Grant/award (A): 54,343 (derivative) @ $0EDGAR
2024-03-184Haimovitz Jules — DirectorGrant/award (A): 39,666 (derivative) @ $0 · Grant/award (A): 54,343 (derivative) @ $0EDGAR
2024-03-184PATTI JOSEPH M — DirectorGrant/award (A): 39,666 (derivative) @ $0 · Grant/award (A): 54,343 (derivative) @ $0EDGAR
2023-12-264Rychlik Richard — Corporate Controller and PFOGrant/award (A): 50,000 (derivative) @ $0EDGAR
2023-12-264Birx Deborah — Chief Executive Officer, DirectorGrant/award (A): 200,000 @ $0 · Grant/award (A): 200,000 (derivative) @ $0EDGAR
2023-12-264Peterson Todd C. — DirectorGrant/award (A): 10,461 (derivative) @ $0EDGAR
2023-12-264Kramer Robin — DirectorGrant/award (A): 10,461 (derivative) @ $0EDGAR
2023-12-264Schlesinger Sarah J. — DirectorGrant/award (A): 10,461 (derivative) @ $0EDGAR
2023-12-264Odysseas Kostas D — DirectorGrant/award (A): 10,461 (derivative) @ $0EDGAR
2023-12-264Haimovitz Jules — DirectorGrant/award (A): 10,461 (derivative) @ $0EDGAR
2023-12-264PATTI JOSEPH M — DirectorGrant/award (A): 10,461 (derivative) @ $0EDGAR
2023-01-124Innoviva, Inc. — Director, 10% owner
Innoviva Strategic Opportunities LLC — Director, 10% owner
Purchase (P) @ $30,000,000EDGAR
2022-04-154Morris Duane Alfred — VP of OperationsGrant/award (A): 41,000 (derivative) @ $0EDGAR
2022-04-154Patrick Todd — DirectorGrant/award (A): 33,000 (derivative) @ $0EDGAR
2022-04-154Kramer Robin — DirectorGrant/award (A): 33,000 (derivative) @ $0EDGAR
2022-04-154Schlesinger Sarah J. — DirectorGrant/award (A): 33,000 (derivative) @ $0EDGAR
2022-04-154Odysseas Kostas D — DirectorGrant/award (A): 33,000 (derivative) @ $0EDGAR
2022-04-154Haimovitz Jules — DirectorGrant/award (A): 33,000 (derivative) @ $0EDGAR
2022-04-154PATTI JOSEPH M — DirectorGrant/award (A): 33,000 (derivative) @ $0EDGAR

Recent 8-K events — Armata Pharmaceuticals, Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2026-11-128-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-09-238-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-09-148-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-128-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-07-208-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
9.01 — Financial Statements and Exhibits
EDGAR
2026-07-208-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-07-138-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-06-248-K/A5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2026-06-238-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-06-168-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=ARMP returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs